Stay updated on Ampyra Optic Neuritis in MS Clinical Trial
Sign up to get notified when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.

Latest updates to the Ampyra Optic Neuritis in MS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMajor update to page status: announces a funding lapse impact and that the NIH Clinical Center is open, plus a new version v3.2.0; removes the old v3.1.0.SummaryDifference2%
- Check23 days agoChange DetectedPage now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to revision v3.0.2, replacing v3.0.1. A 'Back to Top' link was removed.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as new topics related to drug safety and counterfeit drugs. Notably, the previous references to multiple sclerosis and related genetic topics have been removed.SummaryDifference2%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Ampyra Optic Neuritis in MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.